You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
博暉創新(300318.SZ)擬收購領航量子部分股權並對其增資 將持有其67.12%股權
格隆匯 09-11 20:14

格隆匯 9 月 11日丨博暉創新(300318.SZ)公佈,為進一步擴大檢驗檢測業務發展,公司於近日與常州領航量子生物醫療科技有限公司(“領航量子”或“目標公司”)股東高省、屠明玉、楊萬斌簽訂《關於常州領航量子生物醫療科技有限公司之股權轉讓協議》,以現金2400萬元人民幣收購其持有的領航量子共計50%股權;同時公司與領航量子各股東簽訂《增資擴股協議》,公司將以2500萬元認購領航量子新增註冊資本156.25萬元,增資完成後公司將持有領航量子67.12%。另外,公司與領航量子各股東簽訂《股權持續收購協議》,在各方已遵守前述《股權轉讓協議》及《增資擴股協議》的前提下,公司將按照協議約定的條件向老股東持續收購其持有領航量子的股權。此次交易完成後,領航量子將成為公司控股子公司,納入公司合併報表範圍。

領航量子是一家體外診斷試劑和儀器研發、生產與銷售一體化的公司,開發了一系列量子點免疫熒光檢測產品。此次受讓領航量子50%股權並進行增資,主要目的在於擴充公司體外診斷業務免疫方向的產品線,領航量子所擁有的量子熒光技術符合公司一直堅持的技術創新路線,以此為特點的免疫產品將成為公司未來發展的一個重要方向。

此次股權轉讓及增資擴股完成後,領航量子將成為公司控股子公司,領航量子在經營過程中所面臨的市場風險、技術風險、政策風險也將一定程度上對公司產生影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account